The Department of Health (DOH) has formed a task force to attend to the concerns of those who received the dengue vaccine Dengvaxia after it was found out that the drug could lead to severe infections. “The Department of Health (DOH) has created a task force for the management of concerns related to the school-based immunization initiative using the tetravalent dengue vaccine. This is part of the agency’s commitment to closely monitor and attend to the health of those immunized with the vaccine,” Health Secretary Francisco Duque III said in a Palace briefing. Duque on Thursday said the government intends to sue Sanofi after authorities suspended the company’s Dengvaxia vaccine. He said PhilHealth’s dengue case rate can cover up to P16,000 for severe dengue which includes hospital and physician fees.

Source: Philippine Daily Inquirer December 08, 2017 07:30 UTC